Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;4(3):198-202.

Facts and myths in serological screening of ART couples

E V Mocanu  1
Affiliations

Facts and myths in serological screening of ART couples

E V Mocanu. Facts Views Vis Obgyn. 2012.

Abstract

Serological screening of couples attending for ART therapy is now common practice. The frequency of such screening is a topic of debate as few publications have addressed this question. Emerging evidence shows that the ART population has similar prevalence of infectious diseases compared with the general EU population. The need to pursue repeat screening is mainly related to the risk of seroconversion in this highly selected population. The -evidence presented here shows that seroconversion among cohabitating ART couples is negligible. Even if a -theoretical risk of seroconversion during therapy exists, with correct laboratory practice the risk of cross--contamination is negligible as laboratory processing eliminates the infective risk. As such ART laboratory processing of contaminated samples becomes an indication rather than a risk. To strengthen the evidence it is recommended that data on prevalence and incidence should be prospectively collected by all ART units.

Keywords: ART; European reports; assisted reproduction; incidence; prevalence; seroconversion risk; serological viral screening.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Context of EUTCD in the ART process (partner donation).
Fig. 2
Fig. 2. Steps where cross-contamination can occur in ART.
See this image and copyright information in PMC

References

    1. Abusheikha N, Akagbosu F, Marcus S, et al. Viral screening and assisted conception treatment – the Bourn Hall experience. J Assist Reprod Genet. 1999;16:337–339. - PMC - PubMed
    1. Araneta MR, Mascola L, Eller A, et al. HIV transmission through donor artificial insemination. JAMA. 1995;273(11):854–858. - PubMed
    1. Bujan L, Hollander L, Coudert M, et al. Safety and efficacy of sperm washing in HIV-1 serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS. 2007;12:1909–1914. - PubMed
    1. ECDC Technical Reports. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Technical Report ECDC (European Centre for Disease Prevention and Control) 2010. pp. 1–51.
    1. European Commission. Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. 2006.

LinkOut - more resources